Studies of Avian Influenza Transmission to Humans in Egypt
NCT01150552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2014-07-14
Summary
The main focus of the study is:
* To estimate seroprevalence of AI in poultry-exposed and non-exposed human populations.
* To estimate the incidence of AI in poultry-exposed and non-exposed human populations.
* To investigate risk factors associated with AI infections in occupationally-exposed poultry workers.
The secondary objectives of the study:
* To investigate patterns in transmission of AI to household contacts of AI clinical cases
* To isolate AI viruses from acute cases
* To monitor the pathogenicity and disease severity of AI viruses causing human infections
Conditions
- Avian Influenza
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Ghazi Kayali, Ph.D · St. Jude Children's Research Hospital
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- Egypt
Study Locations
More Related Trials
-
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults
NCT00853255 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of an Oral Vaccine to Prevent Avian Influenza
NCT01335347 ·Status: COMPLETED ·Phase: PHASE1
-
Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon
NCT01298206 ·Status: COMPLETED
-
H5N1 Priming and Boosting Strategies
NCT00703053 ·Status: COMPLETED ·Phase: PHASE2
-
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
NCT00417560 ·Status: WITHDRAWN ·Phase: NA
-
Safety Study of Avian Flu Vaccine
NCT00408109 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Vaccine for Prevention of Bird Flu
NCT00776711 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7
NCT00922259 ·Status: COMPLETED ·Phase: PHASE1
-
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults
NCT00516035 ·Status: COMPLETED ·Phase: PHASE1
-
Herd Immunity and Influenza Vaccine Uptake
NCT03748160 ·Status: COMPLETED ·Phase: NA
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies
NCT01270685 ·Status: WITHDRAWN
-
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
NCT00971906 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
NCT03315104 ·Status: COMPLETED ·Phase: PHASE2
-
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
NCT02124096 ·Status: COMPLETED
-
Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers
NCT04223544 ·Status: UNKNOWN
-
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
NCT01769430 ·Status: COMPLETED
-
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
NCT00973349 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children
NCT00446628 ·Status: COMPLETED ·Phase: NA
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)
NCT00110279 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00289510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Asymptomatic Flu Project
NCT02868658 ·Status: COMPLETED ·Phase: NA
-
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556 ·Status: NOT_YET_RECRUITING ·Phase: NA